Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tolerability and Immunogenicity Study of Fluval AB Influenza Vaccine in Adults and Elderly Persons

This study has been completed.
Information provided by (Responsible Party):
Omninvest Vaccine Manufacturing, Researching and Trading Ltd. Identifier:
First received: July 26, 2011
Last updated: May 18, 2012
Last verified: May 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)